Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
Descrizione fisica | 1 online resource (526 p.) |
Disciplina |
616.1/24
616.124 |
Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
Soggetto topico | Heart - Hypertrophy |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
Record Nr. | UNINA-9910143294503321 |
Malden, Mass., : Blackwell Futura, c2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
Descrizione fisica | 1 online resource (526 p.) |
Disciplina |
616.1/24
616.124 |
Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
Soggetto topico | Heart - Hypertrophy |
ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
Record Nr. | UNISA-996214611603316 |
Malden, Mass., : Blackwell Futura, c2004 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Diagnosis and management of hypertrophic cardiomyopathy [[electronic resource] /] / edited by Barry J. Maron |
Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
Descrizione fisica | 1 online resource (526 p.) |
Disciplina |
616.1/24
616.124 |
Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
Soggetto topico | Heart - Hypertrophy |
ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
Record Nr. | UNINA-9910830565003321 |
Malden, Mass., : Blackwell Futura, c2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Diagnosis and management of hypertrophic cardiomyopathy / / edited by Barry J. Maron |
Pubbl/distr/stampa | Malden, Mass., : Blackwell Futura, c2004 |
Descrizione fisica | 1 online resource (526 p.) |
Disciplina |
616.1/24
616.124 |
Altri autori (Persone) | MaronBarry J <1941-> (Barry Joel) |
Soggetto topico | Heart - Hypertrophy |
ISBN |
1-280-19730-7
9786610197309 0-470-79903-X 0-470-98746-4 1-4051-4615-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Diagnosis and Management of Hypertrophic Cardiomyopathy; Contents; Foreword; Dedication and Acknowledgments; List of Contributors; 1 Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy; 2 Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy; 3 Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy; 4 Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5 Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management6 Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy; 7 Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy; 8 Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance; 9 Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions 10 Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy11 Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy; 12 Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression; 13 Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy; 14 Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy; 15 Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy 16 United States Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic Cardiomyopathy17 Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy; 18 Alcohol Septal Ablation; 19 Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience; 20 Role of Septal Ablation in a Surgical Center; 21 Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy; 22 Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hypertrophy as a New Indicator of Risk 23 Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy24 Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias; 25 The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies; 26 Importance of Congenital Coronary Artery Anomalies 27 Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program |
Record Nr. | UNINA-9910877204703321 |
Malden, Mass., : Blackwell Futura, c2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|